Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Cooper

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Laryngoscope|February 1, 1991
Electromyography of masticatory muscles in craniomandibular disordersB C Cooper, D L Cooper, F E Lucente
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
High resolution epitope mapping of an anti-DNA autoantibody using model DNA ligandsP C Swanson, B C Cooper, G D Glick
The Laryngoscope|October 1, 1986
Myofacial pain dysfunction: analysis of 476 patientsB C Cooper, M Alleva, D L Cooper, et al.
Pharmacoeconomics|December 9, 1994
Cost effectiveness of roxithromycin versus cefaclor in AustraliaW G Scott, B C Cooper, H M Scott, et al.
Journal of Lower Genital Tract Disease|October 18, 2006
Asymptomatic lung carcinoma presenting with a large vulvar lesionB C Cooper, T E Buekers, C M Flynn, et al.
The European Respiratory Journal|March 8, 2000
Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthmaP N Black, R Scicchitano, C R Jenkins, et al.
The New Zealand Medical Journal|May 25, 1994
Roxithromycin and lower respiratory tract infectionsW G Scott, B C Cooper, H M Scott, et al.
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
Infection|January 1, 1995
Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practiceN C Karalus, J E Garrett, S D Lang, et al.
American Journal of Epidemiology|October 3, 2001
Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devicesT J Laing, D Schottenfeld, J V Lacey, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Laryngoscope|February 1, 1991
Electromyography of masticatory muscles in craniomandibular disordersB C Cooper, D L Cooper, F E Lucente
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
High resolution epitope mapping of an anti-DNA autoantibody using model DNA ligandsP C Swanson, B C Cooper, G D Glick
The Laryngoscope|October 1, 1986
Myofacial pain dysfunction: analysis of 476 patientsB C Cooper, M Alleva, D L Cooper, et al.
Pharmacoeconomics|December 9, 1994
Cost effectiveness of roxithromycin versus cefaclor in AustraliaW G Scott, B C Cooper, H M Scott, et al.
Journal of Lower Genital Tract Disease|October 18, 2006
Asymptomatic lung carcinoma presenting with a large vulvar lesionB C Cooper, T E Buekers, C M Flynn, et al.
The European Respiratory Journal|March 8, 2000
Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthmaP N Black, R Scicchitano, C R Jenkins, et al.
The New Zealand Medical Journal|May 25, 1994
Roxithromycin and lower respiratory tract infectionsW G Scott, B C Cooper, H M Scott, et al.
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
Infection|January 1, 1995
Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practiceN C Karalus, J E Garrett, S D Lang, et al.
American Journal of Epidemiology|October 3, 2001
Potential risk factors for undifferentiated connective tissue disease among women: implanted medical devicesT J Laing, D Schottenfeld, J V Lacey, et al.
Pageof 4